PKD2 anticorps (AA 529-832)
Aperçu rapide pour PKD2 anticorps (AA 529-832) (ABIN1886533)
Antigène
Voir toutes PKD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 529-832
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 529 and 832 of PRKD2
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- PKD2 (Protein Kinase D2 (PKD2))
-
Autre désignation
- PRKD2
-
Sujet
-
The protein encoded by this gene belongs to the protein kinase D (PKD) family of serine/threonine protein kinases.This kinase can be activated by phorbol esters as well as by gastrin via the cholecystokinin B receptor (CCKBR) in gastric cancer cells.It can bind to diacylglycerol (DAG) in the trans-Golgi network (TGN) and may regulate basolateral membrane protein exit from TGN.Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq]
-
Poids moléculaire
- 97 kDa
-
ID gène
- 25865
-
NCBI Accession
- NP_057541, NM_016457
-
Pathways
- cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity
Antigène
-